ATE52141T1 - Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin. - Google Patents

Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin.

Info

Publication number
ATE52141T1
ATE52141T1 AT85307407T AT85307407T ATE52141T1 AT E52141 T1 ATE52141 T1 AT E52141T1 AT 85307407 T AT85307407 T AT 85307407T AT 85307407 T AT85307407 T AT 85307407T AT E52141 T1 ATE52141 T1 AT E52141T1
Authority
AT
Austria
Prior art keywords
immunotest
methods
human prothrombin
determining natural
unusual human
Prior art date
Application number
AT85307407T
Other languages
English (en)
Inventor
Bruce E Furie
Barbara C Furie
Rita A Blanchard
Original Assignee
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Medical Center Inc filed Critical New England Medical Center Inc
Application granted granted Critical
Publication of ATE52141T1 publication Critical patent/ATE52141T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3038—Kidney, bladder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
AT85307407T 1984-10-15 1985-10-15 Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin. ATE52141T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/661,187 US4769320A (en) 1982-07-27 1984-10-15 Immunoassay means and methods useful in human native prothrombin and human abnormal prothorombin determinations
EP85307407A EP0182495B1 (de) 1984-10-15 1985-10-15 Immuntest, Mittel und Verfahren zur Bestimmung von natürlichem und ungewöhnlichem Human-Prothrombin

Publications (1)

Publication Number Publication Date
ATE52141T1 true ATE52141T1 (de) 1990-05-15

Family

ID=24652562

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85307407T ATE52141T1 (de) 1984-10-15 1985-10-15 Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin.

Country Status (5)

Country Link
US (1) US4769320A (de)
EP (1) EP0182495B1 (de)
JP (1) JPS61117457A (de)
AT (1) ATE52141T1 (de)
DE (1) DE3577233D1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258938B1 (en) * 1983-10-28 2001-07-10 Ne Medical Center Hospital, Inc. Method for the purification and isolation of blood clotting proteins using conformation specific antibodies
DE3727610A1 (de) * 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung
US5147779A (en) * 1988-06-01 1992-09-15 Miles Inc. Method for evaluating immunogenicity
US5217870A (en) * 1989-04-28 1993-06-08 Biogen, Inc. Monoclonal antibodies against CDX
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US5532136A (en) * 1993-06-22 1996-07-02 Bionebraska, Inc. Monoclonal antibody assay and kit for detecting metal cations in body fluids
US20020040008A1 (en) * 1995-01-24 2002-04-04 Wagner Denisa D. Method for treating and preventing atherosclerosis
CA2230887A1 (en) * 1996-07-27 1998-02-05 Hiroyoshi Nishihara Light emitting device, socket device and lighting device
US5935802A (en) * 1998-08-10 1999-08-10 Evanston Northwestern Healthcare Research Institute Method of assaying a blood sample for prothrombin
DE19941447C2 (de) * 1999-08-14 2002-06-27 November Ag Molekulare Medizin Verfahren zur indirekten Bestimmung des Blutgerinnungsstatus
WO2001013123A2 (de) * 1999-08-14 2001-02-22 november Aktiengesellschaft Gesellschaft für Molekulare Medizin Verfahren zur indirekten bestimmung des blutgerinnungsstatus
KR100988188B1 (ko) * 2002-12-26 2010-10-18 니토 보세키 가부시기가이샤 면역 측정 방법 및 그것에 이용하는 키트
TWI700293B (zh) 2008-04-11 2020-08-01 日商中外製藥股份有限公司 重複結合複數個抗原的抗體
TWI440469B (zh) 2008-09-26 2014-06-11 Chugai Pharmaceutical Co Ltd Improved antibody molecules
US8283162B2 (en) 2009-03-10 2012-10-09 Abbott Laboratories Antibodies relating to PIVKAII and uses thereof
KR102568454B1 (ko) * 2010-11-30 2023-08-18 추가이 세이야쿠 가부시키가이샤 복수 분자의 항원에 반복해서 결합하는 항원 결합 분자
EP3604330A1 (de) 2011-02-25 2020-02-05 Chugai Seiyaku Kabushiki Kaisha Fcgammariib-spezifischer fc-antikörper
TW201817745A (zh) 2011-09-30 2018-05-16 日商中外製藥股份有限公司 具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子
JP6322411B2 (ja) 2011-09-30 2018-05-09 中外製薬株式会社 複数の生理活性を有する抗原の消失を促進する抗原結合分子
TWI656133B (zh) 2014-12-19 2019-04-11 日商中外製藥股份有限公司 抗肌抑素之抗體、含變異Ｆｃ區域之多胜肽及使用方法
KR101838645B1 (ko) 2014-12-19 2018-03-14 추가이 세이야쿠 가부시키가이샤 항-c5 항체 및 그의 사용 방법
WO2016125495A1 (en) 2015-02-05 2016-08-11 Chugai Seiyaku Kabushiki Kaisha Antibodies comprising an ion concentration dependent antigen-binding domain, fc region variants, il-8-binding antibodies, and uses therof
EP3263132B1 (de) 2015-02-27 2023-12-06 Chugai Seiyaku Kabushiki Kaisha Zusammensetzung zur behandlung von il-6-assoziierten erkrankungen
WO2017110981A1 (en) 2015-12-25 2017-06-29 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
CN107727864A (zh) * 2016-07-01 2018-02-23 首都医科大学附属北京佑安医院 一种检测血清中异常脱羧凝血酶原的蛋白芯片、试剂盒及其制备方法
CN109689099B (zh) 2016-08-05 2023-02-28 中外制药株式会社 用于预防或治疗il-8相关疾病的组合物
WO2018139623A1 (en) 2017-01-30 2018-08-02 Chugai Seiyaku Kabushiki Kaisha Anti-sclerostin antibodies and methods of use
EP3620531A4 (de) 2017-05-02 2021-03-17 National Center of Neurology and Psychiatry Verfahren zur vorhersage und beurteilung der therapeutischen wirkung bei erkrankungen im zusammenhang mit il-6 und neutrophilen
AU2019225476A1 (en) 2018-02-20 2020-09-10 Pavonis Diagnostics Inc. Aluminum oxide surfaces and interface molecules
CN121260243A (zh) * 2025-10-20 2026-01-02 北京青莲百奥生物科技有限公司 一种预测结直肠癌不同进展阶段的方法、设备、介质和程序产品

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6060557A (ja) * 1983-09-13 1985-04-08 Eisai Co Ltd Ｐｉｖｋａ−２の測定方法および試薬

Also Published As

Publication number Publication date
JPH0441000B2 (de) 1992-07-06
US4769320A (en) 1988-09-06
EP0182495A1 (de) 1986-05-28
JPS61117457A (ja) 1986-06-04
DE3577233D1 (de) 1990-05-23
EP0182495B1 (de) 1990-04-18

Similar Documents

Publication Publication Date Title
ATE52141T1 (de) Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin.
DE3586159D1 (de) Zusammensetzung und verfahren zur differenzierung von weissen blutzellen.
DE68923981D1 (de) Verfahren zur Bestimmung von Textteilen und Verwendung.
DE68903884D1 (de) Mittel und methode zur bestimmung von spurenmengen an proteinen.
DE3863285D1 (de) Verfahren und reagenz zur bestimmung von persaeuren.
ATA328286A (de) Zell-linien und verfahren zur herstellung von humanen monoklonalen antikörpern sowie kit und verfahren zur bestimmung der anwesenheit von p.aeruginosa
ATE148923T1 (de) Funktioneller test und reagenz zur bestimmung von fibrinogen
AT389590B (de) Verfahren zur kontinuierlichen, quantitativen bestimmung von schwefeldioxid und anordnung zur durchfuehrung des verfahrens
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
AT363617B (de) Verfahren zur direkten bestimmung von eisen im blutserum und reagens zur durchfuehrung des verfahrens
DE3485615D1 (de) Reinigung eines krebsassoziierten proteins und herstellung eines antikoerpers dazu.
DE3668068D1 (de) Mittel und verfahren zur bestimmung von calcium.
DE3580771D1 (de) Standardmaterial zur messung von immunologischen komplexen und verfahren zur messung von immunologischen komplexen.
DE3889765D1 (de) Reagens und Verfahren zur Bestimmung von Kationen.
DE3777460D1 (de) Verfahren zur bestimmung von leitendem material in glasfasern und geraet dazu.
AT362530B (de) Verfahren und reagens zur bestimmung von glutamat-oxalacetat-transaminase und glutamat- -pyruvat-transaminase
PT85992A (de) Verfahren zur bestimmung von anti-hiv, mittel dazu und ihre verwendung in diesem verfahren
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
DE3785380D1 (de) Analytische zusammensetzung, element und verfahren zur bestimmung von wasserstoffperoxid.
ATE137864T1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
ATA338987A (de) Verfahren zur bestimmung von anti-p.falciparum- sporozoit-antikörpern im menschlichen blut
FI841145A7 (fi) Menetelmä hemoglobiinipitoisuuden kvantitatiiviseksi määrittämiseksi biologisessa näytteessä.
EP0269677A4 (de) Testverfahren und antikörper für n-myc-proteine.
DE3883808D1 (de) Testsatz, Extraktionsvorrichtung und Verfahren zur Bestimmung von Streptococcus-A-Antigen.
DE59208543D1 (de) Künstliche Standard- und Kontrollseren zur Verwendung in Verfahren zur Bestimmung von Antikörpern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee